Sonova Holding AG (SWX:SOON)

Switzerland flag Switzerland · Delayed Price · Currency is CHF
204.80
+0.60 (0.29%)
Jun 2, 2026, 5:30 PM CET
Market Cap12.13B -23.6%
Revenue (ttm)3.61B -4.8%
Net Income430.60M -22.1%
EPS7.22 -21.9%
Shares Out 59.40M
PE Ratio22.66
Forward PE19.18
Dividend4.70 (2.30%)
Ex-Dividend DateJun 19, 2026
Volume178,950
Open204.40
Previous Close204.20
Day's Range201.00 - 206.20
52-Week Range163.00 - 261.00
Beta1.07
AnalystsHold
Price Target216.51 (+5.72%)
Earnings DateMay 18, 2026

About Sonova Holding AG

Sonova Holding AG manufactures and sells hearing care solutions for children and adults in Switzerland, the United States, rest of the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates through Hearing Instruments, Cochlear Implants, and Lifestyle-Aligned segments. The Hearing Instruments segment engages in the design, development, manufacture, distribution, and service of hearing instruments and related products, as well as wireless headsets, speech-enhanced hearables, and audiophile headphones under the Phonak, Unitr... [Read more]

Sector Healthcare
Founded 1947
Employees 18,590
Stock Exchange SIX Swiss Exchange
Ticker Symbol SOON
Full Company Profile

Financial Performance

In fiscal year 2026, Sonova Holding AG's revenue was 3.61 billion, a decrease of -0.19% compared to the previous year's 3.61 billion. Earnings were 430.60 million, a decrease of -20.33%.

Financial Statements

Analyst Summary

According to 19 analysts, the average rating for SOON stock is "Hold." The 12-month stock price target is CHF 216.51, which is an increase of 5.72% from the latest price.

Price Target
CHF 216.51
(5.72% upside)
Analyst Consensus: Hold
Stock Forecasts

News

Sonova price target raised to CHF 189 from CHF 163 at JPMorgan

JPMorgan analyst David Adlington raised the firm’s price target on Sonova (SONVY) to CHF 189 from CHF 163 and keeps a Neutral rating on the shares.

13 days ago - TheFly

Sonova Holding AG Transcript: H2 25/26

Delivered strong sales and profit growth, driven by innovation and market share gains in hearing instruments and retail, while cochlear implants faced headwinds. Outlook for 2026-2027 is positive, with continued above-market growth and margin expansion expected.

15 days ago - Transcripts

Sonova Holding AG Earnings release: H2 2026

Sonova Holding AG released its H2 2026 earnings on May 18, 2026, summarizing the period's financial results.

15 days ago - Filings

Sonova Holding AG Annual report: H2 2026

Sonova Holding AG has published its H2 2026 annual report on May 18, 2026.

15 days ago - Filings

Sonova Holding AG Slides: H2 2026

Sonova Holding AG has posted slides in relation to its H2 2026 quarterly earnings report, which was published on May 18, 2026.

15 days ago - Filings

Sonova Holding AG (XSWX:SOON) Q4 2026 Earnings Report Preview: What To Look For

Sonova Holding AG (XSWX:SOON) Q4 2026 Earnings Report Preview: What To Look For

18 days ago - GuruFocus

Sonova price target lowered to CHF 169 from CHF 210 at Citi

Citi lowered the firm’s price target on Sonova (SONVY) to CHF 169 from CHF 210 and keeps a Sell rating on the shares.

20 days ago - TheFly

Sonova price target lowered to CHF 172 from CHF 184 at Morgan Stanley

Morgan Stanley lowered the firm’s price target on Sonova (SONVY) to CHF 172 from CHF 184 and keeps an Underweight rating on the shares.

7 weeks ago - TheFly

Sonova upgraded to Neutral from Underweight at JPMorgan

JPMorgan upgraded Sonova (SONVY) to Neutral from Underweight with a price target of CHF 163, up from CHF 158. The firm sees the end of negative estimate revisions for Sonova.

2 months ago - TheFly

Sonova price target lowered to CHF 188 from CHF 237 at Deutsche Bank

Deutsche Bank analyst Falko Friedrichs lowered the firm’s price target on Sonova (SONVY) to CHF 188 from CHF 237 and keeps a Hold rating on the shares. Published first on…

2 months ago - TheFly

Sonova price target lowered to CHF 158 from CHF 176 at JPMorgan

JPMorgan analyst David Adlington lowered the firm’s price target on Sonova (SONVY) to CHF 158 from CHF 176 and keeps an Underweight rating on the shares.

2 months ago - TheFly

Sonova Holding AG Transcript: Investor update

A refreshed strategy aims for CHF 6 billion revenue by FY 2031, focusing on hearing care, innovation, and operational excellence. Growth will be driven by market share gains, Asia expansion, and disciplined M&A, with midterm targets of 5%-10% sales CAGR and 7%-12% core EBIT CAGR.

2 months ago - Transcripts

Sonova Holding AG Press release: Investor update

Sonova Holding AG issued a press release on March 23, 2026, disclosing material business information to investors.

2 months ago - Filings

Sonova Holding AG Slides: Investor update

Sonova Holding AG has posted slides in relation to its latest quarterly earnings report, which was published on March 23, 2026.

2 months ago - Filings

Sonova downgraded to Underperform from Hold at Jefferies

Jefferies downgraded Sonova (SONVY) to Underperform from Hold with a price target of CHF 155, down from CHF 215. The stock’s valuation “remains rich” given the company’s slowing growth prospects,…

2 months ago - TheFly

Sonova upgraded to Outperform from Underperform at BNP Paribas

BNP Paribas upgraded Sonova (SONVY) to Outperform from Underperform with a CHF 230 price target

3 months ago - TheFly

Sonova expects FY revenue at lower end of target range, CEO says in interview

Sonova's full year revenue will come at the lower end of its 2025/2026 forecast range for growth of 5% to 9%, hearing-aid maker CEO Eric Bernard said in an interview published on Friday.

3 months ago - Reuters

Sonova initiated with an Outperform at RBC Capital

RBC Capital initiated coverage of Sonova (SONVY) with an Outperform rating and CHF 250 price target The firm sees the company’s “market leadership positioning and technological differentiation” drivin...

7 months ago - TheFly

Sonova price target lowered to CHF 176 from CHF 195 at JPMorgan

JPMorgan lowered the firm’s price target on Sonova (SONVY) to CHF 176 from CHF 195 and keeps an Underweight rating on the shares.

7 months ago - TheFly

Sonova Holding AG Transcript: H1 25/26

Sales and EBITDA grew strongly in local currencies, led by innovation in hearing instruments and audiological care, while FX and market headwinds impacted reported results. Guidance for 5-9% sales growth and 14-18% EBITDA growth at constant FX is reiterated.

7 months ago - Transcripts

Sonova Holding AG Quarterly report: H1 2026

Sonova Holding AG has published its H1 2026 quarterly earnings report on November 14, 2025.

7 months ago - Filings

Sonova Holding AG Slides: H1 2026

Sonova Holding AG has posted slides in relation to its H1 2026 quarterly earnings report, which was published on November 14, 2025.

7 months ago - Filings

Sonova price target lowered to CHF 237 from CHF 248 at Deutsche Bank

Deutsche Bank lowered the firm’s price target on Sonova (SONVY) to CHF 237 from CHF 248 and keeps a Hold rating on the shares.

7 months ago - TheFly

Sonova re-initiated with an Underperform at BNP Paribas Exane

BNP Paribas Exane re-initiated coverage of Sonova (SONVY) with an Underperform rating and CHF 195 price target The firm cites the company’s “weak” end markets and intense competition for the…

8 months ago - TheFly

Sonova upgraded to Neutral from Sell at Rothschild & Co Redburn

Rothschild & Co Redburn analyst Issie Kirby upgraded Sonova (SONVY) to Neutral from Sell with a price target of CHF 215, up from CHF 210. The firm says the weaker…

8 months ago - TheFly